Nicole Vincent Jordan
About Nicole Vincent Jordan
Nicole Vincent Jordan is a Senior Principal Scientist in Cancer Drug Discovery at Bristol Myers Squibb, with extensive experience in cancer research and drug development.
Company
Nicole Vincent Jordan currently works at Bristol Myers Squibb, a global biopharmaceutical company known for its significant contributions to cancer drug discovery and other therapeutic areas. She holds the position of Senior Principal Scientist, Cancer Drug Discovery, in the Cambridge, Massachusetts office.
Title
Nicole Vincent Jordan is the Senior Principal Scientist, Cancer Drug Discovery, at Bristol Myers Squibb. She previously served as Principal Scientist, Cancer Drug Discovery at the same company.
Education and Expertise
Nicole Vincent Jordan earned her Doctor of Philosophy (Ph.D.) in Pharmacology from the University of North Carolina at Chapel Hill, where she studied from 2007 to 2012. She also holds a Bachelor’s degree in Biochemistry from Indiana University Bloomington, completed between 2001 and 2005. Her main areas of expertise include using in vivo mouse models, ex vivo cell co-culture models, genomics, and transcriptomics to advance target identification and validation in cancer biology.
Career Background
Nicole Vincent Jordan has built a robust career across various prestigious organizations in the pharmaceutical and biotechnology sectors. At Bristol Myers Squibb, she transitioned from Principal Scientist, Cancer Drug Discovery, to her current role as Senior Principal Scientist. Prior to this, she was with Novartis Institutes for BioMedical Research (NIBR), where she served as Principal Scientist II and Principal Scientist I/Investigator II, Oncology Biotherapeutics. She has also held research positions at Massachusetts General Hospital, UNC Chapel Hill, Baxter, and Eli Lilly and Company.
Research and Development Experience
Nicole Vincent Jordan has vast experience in cancer drug discovery and development, focusing on antibody-, nanobody-, and peptide-based therapies. She led a project team developing CD3-bispecific therapies and has significant proficiency with in vivo mouse models and ex vivo cell co-culture models in her cancer research. Her work extends to elucidating cancer cell intrinsic dependencies in breast, ovarian, and lung cancers.
Leadership and Collaboration
Nicole Vincent Jordan is noted for her dynamic and inclusive leadership style, which fosters team excellence and motivation. She has collaborated successfully with multi-disciplinary teams in the realm of cancer drug discovery, contributing to the development of impactful therapeutic strategies.